Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4326-4335. doi:…
Evolutionary Changes after Translational Challenges Imposed by Horizontal Gene Transfer
Genome Biol Evol. 2019 Mar 1;11(3):814-831. doi: 10.1093/gbe/evz031.ABSTRACTGenes…
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Oncol. 2019 Mar;20(3):408-419. doi: 10.1016/S1470-2045(18)30860-X.…
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3604-3613. doi:…
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study
Lancet Haematol. 2019 Feb;6(2):e89-e99. doi: 10.1016/S2352-3026(18)30214-X.ABSTRACTBACKGROUND:…
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
J Immunother Cancer. 2019 Jan 25;7(1):19. doi: 10.1186/s40425-019-0505-4.ABSTRACTBACKGROUND:…
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Sci Transl Med. 2019 Jan 23;11(476):eaat9321. doi: 10.1126/scitranslmed.aat9321.ABSTRACTRetinoblastoma…
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
J Clin Oncol. 2019 Feb 20;37(6):490-503. doi: 10.1200/JCO.18.00358.…
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1
J Immunol. 2019 Feb 1;202(3):787-798. doi: 10.4049/jimmunol.1800717.…
Treating atherosclerosis: targeting risk factors should not be the only option
Ann Transl Med. 2018 Nov;6(Suppl 1):S34. doi: 10.21037/atm.2018.09.40.NO…
Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients
Gynecol Oncol. 2019 Feb;152(2):270-277. doi: 10.1016/j.ygyno.2018.11.036.…
NSD2 is a conserved driver of metastatic prostate cancer progression
Nat Commun. 2018 Dec 5;9(1):5201. doi: 10.1038/s41467-018-07511-4.ABSTRACTDeciphering…
